Document Page: First | Prev | Next | All | Image | This Release | Search
File: 970107_sep96_decls14_0002.txt
Subject: MEDICAL PROD UNDER FDA REG REQUIRED CONSIDER FOR DEPLOYMENT
Unit: OTSG
Parent Organization: HSC
Box ID: BX003201
Folder Title: MEDICAL PRODUCTS UNDER FDA REGULATIONS
Document Number: 930001
Folder Seq #: 930000
2. Ribavirin Injection, IV, 1 gram vials in a 10 ml buffered
solution.
a. IND # 16,666, sponsored by the US Army Office of the
Surgeon General. Viratech sponsors three INDS: #9076 for oral
and injectable ribavirin, #17111 for aerosol, and #27296 (?).
CDC sponsors IND #17186 for ribavirin(?). Lederle sponsors IND
#10293.
b. NDA 18-859 is approved for aerosolized ribavirin for the
treatment of respiratory syncytial virus in infants.
b. Manufacturer: Viratech
C. IND listed indication: Hemorrhagic Fever with Renal
Syndrome. The indication intended for use in Operation Desert
Shield is for the treatment of Crimean Congo Hemorrhagic
Fever,which is a hemorrhagic fever with renal syndrome.
d. Operation Desert shield status: required immediately.
e. Projected Availability for Operation Desert Shield: 7
October 1990.
f. Consequences of nontreatment: 30% mortality untreated.
g. Informed consent status: undetermined
f. Point of Contact: Dr. Liu, 301-663-2051
Document Page: First | Prev | Next | All | Image | This Release | Search
Document 11 f:/Week-36/BX003201/MEDICAL PRODUCTS UNDER FDA REGULATIONS/medical prod under fda reg required consider for:01029715471415
Control Fields 17
File Room = sep96_declassified
File Cabinet = Week-36
Box ID = BX003201
Unit = OTSG
Parent Organization = HSC
Folder Title = MEDICAL PRODUCTS UNDER FDA REGULATIONS
Folder Seq # = 930000
Subject = MEDICAL PROD UNDER FDA REG REQUIRED CONSIDER FOR
Document Seq # = 930001
Document Date =
Scan Date =
Queued for Declassification = 01-JAN-1980
Short Term Referral = 01-JAN-1980
Long Term Referral = 01-JAN-1980
Permanent Referral = 01-JAN-1980
Non-Health Related Document = 01-JAN-1980
Declassified = 02-JAN-1997